Prescribing trends of sodium-glucose cotransporter 2 inhibitors in patients with heart failure with preserved, mildly reduced and reduced ejection fraction
Eur Heart J Cardiovasc Pharmacother
.
2023 Sep 20;9(6):505-506.
doi: 10.1093/ehjcvp/pvad022.
Authors
Felix Hofer
1
,
Andreas Hammer
1
,
Eva Steinacher
1
,
Ulrike Baumer
1
,
Niema Kazem
1
,
Lorenz Koller
1
,
Bernhard Richter
1
,
Christian Hengstenberg
1
,
Patrick Sulzgruber
1
,
Alexander Niessner
1
Affiliation
1
Department of Internal Medicine II, Division of Cardiology, Medical University of Vienna, Waehringer Guertel 18-20, 1090 Vienna, Austria.
PMID:
36963781
DOI:
10.1093/ehjcvp/pvad022
No abstract available
Publication types
Letter
MeSH terms
Glucose
Heart Failure* / diagnosis
Heart Failure* / drug therapy
Humans
Sodium
Stroke Volume
Ventricular Dysfunction, Left*
Substances
Glucose
Sodium